المؤلفون: Metselaar, D, ter Huizen, G, Meel, MH, Goulding, J, Waranecki, P, Carcaboso AM, Kaspers, G, Hulleman, E

المصدر: Neuro-Oncology
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::18053801bbd0e59ea12a6247ac80afc9
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=19212

المؤلفون: Meel MH, de Gooijer MC, Guillén Navarro M, Waranecki P, Breur M, Buil L, Wedekind LE, Twisk JWR, Koster J, Hashizume R, Raabe EH, Carcaboso AM, Bugiani M, van Tellingen O, van Vuurden DG, Kaspers GJL, Hulleman E

المصدر: CLINICAL CANCER RESEARCH
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::24b2abc730e58ea575cfc01abada2388
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14709

المؤلفون: Sewing AC, Lagerweij T, van Vuurden DG, Meel MH, Veringa SJ, Carcaboso AM, Gaillard PJ, Peter Vandertop W, Wesseling P, Noske D, Kaspers GJ, Hulleman E

المصدر: JOURNAL OF NEUROSURGERY-PEDIATRICS
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

مصطلحات موضوعية: MTD = maximum tolerated dose, anthracyclines, convection-enhanced delivery, VUMC = VU University Medical Center, pHGG = pediatric high-grade glioma, pHGG, diffuse intrinsic pontine glioma, CED = convection-enhanced delivery, doxorubicin, IC50 = half maximal inhibitory concentration, DIPG = diffuse intrinsic pontine glioma, LG-BSG = low-grade brainstem glioma, BBB = blood-brain barrier, thalamus, oncology, DIPG, pediatric high-grade glioma, BLI = bioluminescent imaging, TOPIIA = topoisomerase Type IIA, GBM = glioblastoma multiforme, CED, PLD = pegylated liposomal doxorubicin, PBS = phosphate-buffered saline

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3d3e4c1e1061337ee07dca38a8fa32aa
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11021

المؤلفون: Metselaar DS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Meel MH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Goulding JR; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., du Chatinier A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Rigamonti L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Waranecki P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Geisemeyer N; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Pediatric Neuro-Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., de Gooijer MC; Division of Pharmacology/Mouse Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Breur M; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Koster J; Department of Epidemiology and Biostatistics, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Veldhuijzen van Zanten SEM; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands., Bugiani M; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Franke NE; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Reddy A; Departments of Neurology and Pediatrics, University of California San Francisco, San Francisco, CA, USA., Wesseling P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Hulleman E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands. Electronic address: e.hulleman@prinsesmaximacentrum.nl.

المصدر: Cell reports. Medicine [Cell Rep Med] 2024 Aug 20, pp. 101700. Date of Electronic Publication: 2024 Aug 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

المؤلفون: Vazaios K; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands., Stavrakaki Ε; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Vogelezang LB; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Ju J; Department of Pathology and Clinical Bioinformatics, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Waranecki P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Metselaar DS; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Meel MH; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands.; Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA Utrecht, the Netherlands., Kemp V; Department of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the Netherlands., van den Hoogen BG; Department of Viroscience, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Hoeben RC; Department of Cell and Chemical Biology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the Netherlands., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Goins WF; Department of Microbiology & Molecular Genetics, University of Pittsburgh School of Medicine, 450 Technology Dr, Pittsburgh, PA 15219, USA., Stubbs A; Department of Pathology and Clinical Bioinformatics, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Li Y; Department of Pathology and Clinical Bioinformatics, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands., Alonso MM; Program in Solid Tumors, Center for Applied Medical Research (CIMA), Avda. de Pío XII, 55, 31008 Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Av. de Pío XII, 36, 31008 Pamplona, Spain.; Health Research Institute of Navarra (IDISNA), Av. de Pío XII, 36, 31008 Pamplona, Spain., Calkoen FG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Hulleman E; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Lamfers MLM; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.

المصدر: Molecular therapy. Oncology [Mol Ther Oncol] 2024 Apr 15; Vol. 32 (2), pp. 200804. Date of Electronic Publication: 2024 Apr 15 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE

المؤلفون: du Chatinier A; Department of Neuro-oncology, Princess Máxima Center for Paediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands., Velilla IQ; Department of Neuro-oncology, Princess Máxima Center for Paediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands., Meel MH; Department of Neuro-oncology, Princess Máxima Center for Paediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands., Hoving EW; Department of Neuro-oncology, Princess Máxima Center for Paediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands., Hulleman E; Department of Neuro-oncology, Princess Máxima Center for Paediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands., Metselaar DS; Department of Neuro-oncology, Princess Máxima Center for Paediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands. Electronic address: d.s.metselaar@prinsesmaximacentrum.nl.

المصدر: Cell reports. Medicine [Cell Rep Med] 2023 Nov 21; Vol. 4 (11), pp. 101246. Date of Electronic Publication: 2023 Nov 03.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

مواضيع طبية MeSH: Microglia*/physiology , Brain Neoplasms*/therapy, Child ; Humans ; Central Nervous System ; Brain ; Immunotherapy

المؤلفون: du Chatinier A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Meel MH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Das AI; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Metselaar DS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Waranecki P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bugiani M; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Breur M; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Simonds EF; Departments of Neurology, Neurological Surgery, and Pediatrics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Lu ED; Departments of Neurology, Neurological Surgery, and Pediatrics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Weiss WA; Departments of Neurology, Neurological Surgery, and Pediatrics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Garcia Vallejo JJ; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Hoving EW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Phoenix TN; Division of Pharmaceutical Sciences, College of Pharmacy, University of Cincinnati/Research in Patient Services, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Hulleman E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

المصدر: Neuro-oncology advances [Neurooncol Adv] 2022 May 24; Vol. 4 (1), pp. vdac079. Date of Electronic Publication: 2022 May 24 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

المؤلفون: Metselaar DS; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands.; Emma Children's Hospital, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands., du Chatinier A; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands., Meel MH; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands., Ter Huizen G; Emma Children's Hospital, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands., Waranecki P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands., Goulding JR; Emma Children's Hospital, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands., Bugiani M; Department of Pathology, Amstrdam University Medical Centers, Amsterdam, the Netherlands., Koster J; Department of Oncogenomics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands.; Emma Children's Hospital, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands., Hulleman E; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584CS Utrecht, the Netherlands.

المصدر: IScience [iScience] 2022 May 13; Vol. 25 (6), pp. 104398. Date of Electronic Publication: 2022 May 13 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

المؤلفون: Wei X; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA., Meel MH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology/Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands., Breur M; Amsterdam Leukodystrophy Center, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Child Neurology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam and Amsterdam Neuroscience, Amsterdam, The Netherlands., Bugiani M; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam and Amsterdam Neuroscience, de Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.; Amsterdam Leukodystrophy Center, Amsterdam UMC, Amsterdam, The Netherlands., Hulleman E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology/Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands., Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA. timothy.phoenix@uc.edu.; Research in Patient Services, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. timothy.phoenix@uc.edu.

المصدر: Acta neuropathologica communications [Acta Neuropathol Commun] 2021 Aug 23; Vol. 9 (1), pp. 142. Date of Electronic Publication: 2021 Aug 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101610673 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-5960 (Electronic) Linking ISSN: 20515960 NLM ISO Abbreviation: Acta Neuropathol Commun Subsets: MEDLINE

مواضيع طبية MeSH: Neurovascular Coupling*/physiology, Brain/*blood supply , Brain/*pathology , Brain Neoplasms/*pathology , Glioma/*pathology , Xenograft Model Antitumor Assays/*methods, Animals ; Blood-Brain Barrier/pathology ; Child ; Humans ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Neoplasm Grading/methods

المؤلفون: Balakrishnan I; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA; The Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA., Danis E; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA; The Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA., Pierce A; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Madhavan K; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA; The Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA., Wang D; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Dahl N; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA; The Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA., Sanford B; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Birks DK; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Davidson N; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Metselaar DS; Princess Máxima Center for Pediatric Oncology, Utrecht and Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Meel MH; Princess Máxima Center for Pediatric Oncology, Utrecht and Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Lemma R; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Donson A; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA; The Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA., Vijmasi T; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA; The Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA., Katagi H; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA., Sola I; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Fosmire S; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Alimova I; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Steiner J; Departments of Radiology, Radiation Oncology, and Anesthesiology, Colorado Animal Imaging Shared Resource (AISR), University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Gilani A; Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA., Hulleman E; Princess Máxima Center for Pediatric Oncology, Utrecht and Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Serkova NJ; Departments of Radiology, Radiation Oncology, and Anesthesiology, Colorado Animal Imaging Shared Resource (AISR), University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Hashizume R; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA., Hawkins C; Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada., Carcaboso AM; Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, Barcelona 08950, Spain., Gupta N; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Monje M; Departments of Neurology, Neurosurgery, Pediatrics, and Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Jabado N; Department of Human Genetics, McGill University, Montreal, QC H3A 1B1, Canada; Department of Pediatrics, McGill University, and The Research Institute of the McGill University Health Center, Montreal, QC H4A 3J1, Canada., Jones K; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA., Foreman N; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA; The Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA., Green A; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA; The Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA., Vibhakar R; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA; The Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA. Electronic address: rajeev.vibhakar@cuanschutz.edu., Venkataraman S; Department of Pediatrics and Section of Pediatric Hematology/Oncology/BMT, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA; The Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, CO, USA. Electronic address: sujatha.venkataraman@cuanschutz.edu.

المصدر: Cell reports [Cell Rep] 2020 Oct 20; Vol. 33 (3), pp. 108286.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

مواضيع طبية MeSH: Aging/*genetics , Diffuse Intrinsic Pontine Glioma/*genetics , Polycomb Repressive Complex 1/*metabolism, Astrocytoma/genetics ; Brain Stem Neoplasms/drug therapy ; Brain Stem Neoplasms/genetics ; Cell Differentiation/genetics ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Child ; Child, Preschool ; Chromatin/genetics ; Diffuse Intrinsic Pontine Glioma/drug therapy ; Diffuse Intrinsic Pontine Glioma/metabolism ; Epigenomics ; Female ; Glioma/drug therapy ; Glioma/genetics ; Glioma/pathology ; Histones/metabolism ; Humans ; Lysine/metabolism ; Male ; Mutation ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Polycomb Repressive Complex 1/antagonists & inhibitors ; Polycomb Repressive Complex 1/genetics